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ABSTRACT
Objective: To explore how different practices
responded to the Data-driven Quality Improvement in
Primary Care (DQIP) intervention in terms of their
adoption of the work, reorganisation to deliver the
intended change in care to patients, and whether
implementation was sustained over time.
Design: Mixed-methods parallel process evaluation of
a cluster trial, reporting the comparative case study of
purposively selected practices.
Setting: Ten (30%) primary care practices
participating in the trial from Scotland, UK.
Results: Four practices were sampled because they
had large rapid reductions in targeted prescribing. They
all had internal agreement that the topic mattered,
made early plans to implement including assigning
responsibility for work and regularly evaluated
progress. However, how they internally organised the
work varied. Six practices were sampled because they
had initial implementation failure. Implementation
failure occurred at different stages depending on
practice context, including internal disagreement about
whether the work was worthwhile, and intention but
lack of capacity to implement or sustain
implementation due to unfilled posts or sickness.
Practice context was not fixed, and most practices with
initial failed implementation adapted to deliver at least
some elements. All interviewed participants valued the
intervention because it was an innovative way to
address on an important aspect of safety (although
one of the non-interviewed general practitioners in one
practice disagreed with this). Participants felt that
reviewing existing prescribing did influence their future
initiation of targeted drugs, but raised concerns about
sustainability.
Conclusions: Variation in implementation and
effectiveness was associated with differences in how
practices valued, engaged with and sustained the work
required. Initial implementation failure varied with
practice context, but was not static, with most
practices at least partially implementing by the end of
the trial. Practices organised their delivery of changed
care to patients in ways which suited their context,
emphasising the importance of flexibility in any future
widespread implementation.
Trial registration number: NCT01425502.
BACKGROUND
High-risk prescribing in primary care is a
major concern for healthcare systems inter-
nationally. Between 2% and 4% of emer-
gency hospital admissions are caused by
preventable adverse drug events (ADEs),1 2
at signiﬁcant cost to healthcare systems.3 4
A large proportion of these admissions
are caused by commonly prescribed drugs,
with non-steroidal anti-inﬂammatory drugs
(NSAIDs) and antiplatelets being frequently
Strengths and limitations of this study
▪ This is a comprehensive, preplanned process
evaluation which includes a third of all practices
which participated in the Data-driven Quality
Improvement in Primary Care (DQIP) stepped-
wedge cluster-randomised trial.
▪ The evaluation sampled four practices which
rapidly implemented the intervention and all six
practices which failed to implement the interven-
tion to some degree.
▪ A strength of the study is the use of qualitative
data from interviews and observational field
notes, and quantitative data about key trial pro-
cesses and practice-level effectiveness to
examine implementation in detail.
▪ A limitation is that we did not collect any data
from practices prior to them receiving the
intervention.
Grant A, et al. BMJ Open 2017;7:e015281. doi:10.1136/bmjopen-2016-015281 1
Open Access Research
implicated, causing gastrointestinal, cardiovascular and
renal adverse events.5–7
The Data-driven Quality Improvement in Primary Care
(DQIP) intervention was systematically developed and
optimised8–10 and comprised three intervention compo-
nents: (1) professional education about the risks of
NSAIDs and antiplatelets via an outreach visit by a
pharmacist; (2) ﬁnancial incentives to review patients at
the highest risk of NSAID and antiplatelet ADEs, split
into a participation fee of £350 and £15 per patient
reviewed and (3) access to a web-based IT tool to iden-
tify such patients and support structured review. The
intervention was evaluated in a pragmatic stepped-wedge
cluster-randomised controlled trial11 in 33 practices
from one Scottish health board, where all participating
practices received the intervention but were randomised
to one of 10 different start dates.8 Across all practices,
targeted high-risk prescribing fell from 3.7% immedi-
ately before to 2.2% at the end of the intervention
period (adjusted OR 0.63 (95% CI 0.57 to 0.68),
p<0.0001). The intervention only incentivised review of
ongoing high-risk prescribing, but led to reductions in
ongoing (adjusted OR 0.60, 95% CI 0.53 to 0.67) and
‘new’ high-risk prescribing (adjusted OR 0.77, 95% CI
0.68 to 0.87). Notably, reductions in high-risk prescrib-
ing were sustained in the year after ﬁnancial incentives
stopped. In addition, there were signiﬁcant reductions
in emergency hospital admissions with gastrointestinal
ulcer or bleeding (risk ratio (RR) 0.66, 95% CI 0.51 to
0.86) and heart failure (RR 0.73, 95% CI 0.56 to 0.95).12
Alongside the main trial, we designed a mixed-
methods process evaluation,13 14 based on a cluster-
randomised trial process evaluation framework which we
developed.15 Our framework emphasises the importance
of considering two levels of intervention delivery and
response that often characterise cluster-randomised
trials of behaviour change interventions (although their
importance will depend on intervention design). The
ﬁrst is the intervention that is delivered to clusters,
which respond by adopting (or not) the intervention
and integrating it with existing work. The second is the
change in care which the cluster professionals deliver to
patients. In DQIP, the delivery of the intervention to pro-
fessionals was predeﬁned, intended to be delivered with
high ﬁdelity across all practices by the research team,
whereas the intervention delivered to patients was at the
discretion of practices, who decided whether and how
they reviewed patients and whether to change prescrib-
ing. We used this framework to structure our parallel
process evaluation, mapping data collection to a logic
model of how the DQIP intervention was expected to
work (ﬁgure 1).
The aim of this analysis is to examine how different
practices responded to the intervention delivered to
them by the research team in terms of their adoption of
the work, their reorganisation to deliver the intended
Figure 1 DQIP process evaluation framework. DQIP, Data-driven Quality Improvement in Primary Care.
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change in care to patients and whether implementation
was sustained over time.
METHODS
The design was a mixed-method comparative case study,
with general practices the unit of analysis.16 17 The
overall design and methods have been described previ-
ously in the published protocol.18 In brief, we used a
mixed-methods parallel process evaluation to examine
the implementation of selected processes and their asso-
ciations with change in high-risk prescribing at practice
level. The quantitative element examined how change in
prescribing at practice level was associated with practice
characteristics and implementation of key processes and
is reported separately (Dreischulte et al. Process evalu-
ation of the Data-driven Quality Improvement in
Primary Care (DQIP) trial: quantitative examination of
representativeness of trial participants and heterogeneity
of impact. Implementation Science 2016, Submitted). The
qualitative element consisted of case studies in 10 of the
33 participating practices. Practice staff perceptions of
the importance of different intervention components
and when they had an effect are reported separately.19
The analysis reported here examines how practices
adopted, implemented and maintained the intervention.
Informed consent was obtained from all participants to
participate and to publish anonymised data.
Case study sampling
Practices were purposively sampled to include those
which had and had not initially reduced high-risk pre-
scribing, judged by visual inspection of run charts of
high-risk prescribing rates ∼4 months after starting the
intervention. Our assumption was change in high-risk
prescribing was a good proxy for initial response to the
intervention delivered to practices. Sampling was addi-
tionally structured to recruit practices starting the trial at
different times, and to ensure a mix of smaller and
larger practices (<5000 and ≥5000 registered patients),
reﬂecting the stepped-wedge trial design and our a
priori belief that smaller practices would more effectively
implement the intervention (randomisation was strati-
ﬁed by list size).18 Ten (30%) practices were sampled
and recruited to the process evaluation, including all six
practices with no initial change in targeted prescribing.
Qualitative data collection
In each practice, the general practitioner (GP) most
involved in the DQIP work (leading the review work), a
GP less involved (who may have been involved in the
review work to some degree), the practice manager and
pharmacist were invited for interview. All interviews were
carried out by AG ∼6 months after the practice started
the intervention, and the GP most involved was inter-
viewed again 3–6 months later to explore changes over
time. Interviews lasted ∼1 hour, and were audio-recorded
and transcribed verbatim. Additional data generated
were ﬁeld notes made by AG during the educational out-
reach visits (EOV), detailing response to the educational
component and informatics tool training. Data gener-
ation took place between September 2011 and
December 2013 in parallel with intervention implemen-
tation. All data have been anonymised, including by
using pseudonyms for practices.
Quantitative data collection
Data from the DQIP IT tool were used to sample prac-
tices using run charts to visually assess change in per-
formance in the ﬁrst 4 months of implementation, but
were not used alongside the qualitative analysis reported
here which was otherwise blind to any quantitative
process or outcome data. Data from the same source
were also used after qualitative analysis was complete to
measure and categorise reach, delivery to the patient
and maintenance. Reach was measured as the percent-
age of patients ﬂagged as needing a review who had
received at least one review, delivery to the patient as the
percentage of ﬂagged patients who had further action in
response to initial review (eg, a medication change, or
an invitation to consult) and maintenance as reach in
the ﬁnal 24 weeks of the intervention period.
Effectiveness was deﬁned as the relative change in the
mean rate of high-risk prescribing trial primary outcome
measure between baseline (the 48 weeks before the
intervention) and the ﬁnal 24 weeks of the intervention.
Quantitative data were only used to explore whether the
qualitative judgements made about implementation
were consistent with observed data on reach, delivery,
maintenance and effectiveness. Associations between
quantitative practice-level process and effectiveness data
will be reported separately (Dreischulte et al 2016,
Submitted).
Researcher expectations of how the intervention
would work
During intervention and process evaluation design, the
research team expected that several processes had to
happen for the intervention to reduce high-risk
prescribing:
1. Practices had to adopt the intervention, in the sense
of being convinced that the work was worthwhile,
engaging with the education and set-up process, and
organising how the work required would be done.20
This is represented by the ‘response of clusters’ box
in ﬁgure 1.
2. Practices would have to deliver the reviews to patients
by using the informatics tool to identify patients, by a
GP initially reviewing the records and taking any
action they judged necessary (eg, to stop the drug, or
review the patient in person, or seek advice from a
specialist). This work is represented by the ‘reach’
and ‘delivery to patient’ boxes in ﬁgure 1.
3. Practices would then have to maintain this activity
over the 48 weeks the intervention was active (‘main-
tenance’ in ﬁgure 1).
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Analysis
Analysis was iterative with data generation to allow issues
and themes identiﬁed to inform subsequent data gener-
ation and facilitate deeper exploration, and continued
until no new themes emerged. Analysis was carried out
by AG with BG contributing through discussion of data
and interpretation until he became aware of the trial
results, and was completed by AG before she knew the
outcome of the trial.
A coding frame was developed inductively and deduct-
ively from ﬁeld notes, initial interviews and topic guides
(available in see online supplementary appendix),
framework15 and logic model,18 and revised during ana-
lysis through use of the constant comparative method.21
NVivo V.8 was used to systematically apply the coding
frame to all data. An in-depth description of each case
study was constructed detailing characteristics and per-
ceptions of all practice staff that participated in inter-
views with additional data from the EOV observation and
informal interviews. This facilitated a detailed explor-
ation on a case-by-case basis. Analysis used the frame-
work technique which facilitated comparing the data by
concept, theme and practice and facilitated cross and
within-case comparisons.22 Analysis drew on normalisa-
tion process theory (NPT), which focuses attention on
how interventions become integrated, embedded and
routinised into social contexts.20 AG analysed the data
collected in the study twice, inductively and deductively
as described above and deductively based on NPT. Each
NPT construct was deﬁned speciﬁcally for DQIP and
these deﬁnitions can be found in table 1. Coding charts
and memos were developed for each NPT construct and
higher order constructs (coherence, cognitive participa-
tion, collective action and reﬂective monitoring). NPT
interpretation and coding reliability were established
through a workshop with NPT experts. The data were
explored for negative cases.
RESULTS
Findings are based on data from 38 interviews (10 lead
GPs of whom 9 were interviewed twice, 7 GPs less
involved with DQIP, 9 practice managers and 3 practice
pharmacists) and from ∼11 hours of ﬁeld notes. Table 2
summarises the practice characteristics and intended
and actual process for delivering the intervention to
patients, ordered by the ﬁnal qualitative judgement
about the extent to which they implemented the inter-
vention as intended by the research team (table 3).
Perceptions of the work required and initial plans to
implement
All GPs interviewed said they believed the targeted pre-
scribing to be a cause of potentially preventable harm
which was worth addressing (although in one practice,
one non-interviewed GP did not believe this—see
below). There was a consistent perception that safety-
focused prescribing improvement work was more
engaging for GPs (and patients) compared with previous
experience of interventions to reduce prescribing cost.
Some GPs reported they had already reviewed NSAID
prescribing under a local health board initiative but
DQIP was more meaningful because it focused on and
identiﬁed individuals at higher risk of adverse events. All
but one interviewed GP perceived the DQIP interven-
tion to be clearly differentiated from existing prescribing
improvement activity, and to be of signiﬁcant value.
Although practices were free to organise the work as
they saw ﬁt, the research team knew approximately half
of patients requiring review over the year would be
Table 1 Normalisation process theory constructs interpreted for the DQIP trial
Coherence
How do participants
understand and attribute
value to DQIP?
Cognitive participation
Enrolment and engagement
of individuals and groups
Collective action
Organising and doing the
work
Reflective monitoring
Reflecting on progress and
making necessary
adjustments
Differentiation
How does DQIP differ from
other prescribing quality
improvement work?
Initiation
Agency—capacity of
individuals to make decisions
and weigh up options.
Interactional workability
How is DQIP
operationalised?
Systematisation
How do practices make
judgements about
effectiveness?
Individual specification
How does DQIP cohere with
other work?
Enrolment
Persuading others to take part
Skill set workability
How is the work allocated?
Roles and responsibilities
Communal appraisal
Regular and organised formal
monitoring and appraisal
Communal specification
Does the team have a
shared understanding of
DQIP?
Legitimation
Buying into the DQIP work:
how or what do they value
about DQIP?
Relational integration
How is DQIP understood
and mediated by the people
around it?
Individual appraisal
Unsystematic and informal
appraisal of DQIP. What are
the conclusions?
Internalisation
What past experiences do
they relate DQIP work to?
Activation
What process have they
decided on to do the work?
What resources are required?
Contextual integration
Incorporation of DQIP into
practice context.
Reconfiguration
Appraisal may lead to
changes—what have they
changed?
DQIP, Data-driven Quality Improvement in Primary Care.
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identiﬁed when the practice started the intervention. At
the educational visit, the research team therefore
encouraged practices to divide the work across more
than one GP, and most practices initially agreed to do
this. However, many found this was either not feasible or
sustainable (eg, where many or most GPs in a practice
worked part-time), or in small practices was not neces-
sary since one GP could comfortably manage the
workload.
However, all practices found this initial volume of
work required dedicated time to complete and could
not be done opportunistically. Three practices
(Mingulay, Lingay and Hirta) allocated administrative
time to carrying out the DQIP reviews, in the remaining
practices the GPs reviewed patients once routine work
was ﬁnished.
…we ended up doing it in the evenings; it was after six
o’clock, so it was sitting here at half past six, seven
o’clock in the evening ploughing through patients’
notes. (Hellisay, GP 2, interview 1)
Case study practices which had not initially reduced
high-risk prescribing
Six practices were sampled on the basis of having no
initial change in high-risk prescribing, and were assumed
by the research team to be initial ‘non-adopters’.
However, the reasons for this varied across practices.
Table 2 Practice characteristics including planned and actual process for delivering care to patients
Practice*
Randomised
group†
Approximate
list size and full
time equivalent
(FTE) GPs
Sampling
(initial change
in prescribing
and size)
Overall
high-risk
prescribing rate
at baseline‡
The process for delivering the
intervention to patients, both planned
by the practice and actual (based on
interview and observational data)
Orosay 2 10 000
6.5 FTE
Not reducing
Large
6.6 Failure to legitimise and no process to
implement agreed, but the most engaged
GP said there was some change in
clinical practice
Boreray 10 6500
3.5 FTE
Not reducing
Large
2.5 Initially agreed to divide the work between
GPs, but failed to implement because of
understaffing/prioritisation of clinical work
Hellisay 9 3000
1.9 FTE
Not reducing
Small
7.0 Initially agreed that one GP would review,
but actually divided the work. Staff
changes meant they could not maintain
reviewing
Mingulay 3 9000
5 FTE
Not reducing
Large
3.2 Initially agreed that one GP would review
all patients in set 2 hours/month. This was
inadequate, and poor GP to GP
communication further reduced impact
Gighay 7 2500
1.9 FTE
Not reducing
Small
3.4 Initially agreed that one GP would review
all patients and flag notes for when next
seen, so relied on patient consulting and
other GPs acting on the flag
Lingay 4 3000
2 FTE
Not reducing
Small
5.0 Initially agreed to divide the work, but did
not implement; one GP systematically and
enthusiastically reviewed after a delay
Scalpay 6 3000
2 FTE
Reducing
Small
3.7 Did not agree process at EOV, but rapid
implementation of one GP systematically
reviewing all patients
Hirta 8 5500
4.3 FTE
Reducing
Large
4.2 Initially agreed to divide the work and
rapidly delivered by all GPs initially
reviewing. Once initial bulk of reviews
done, one GP maintained reviewing
Monach 1 3500
2.7 FTE
Reducing
Small
7.1 Initially agreed to divide the work, but
actually rapid implementation by one GP
doing all the reviewing
Taransay 5 6000
4 FTE
Reducing
Large
3.7 Initially agreed to divide the work, with
rapid implementation by all GPs carrying
out the reviewing
*Ordered from top to bottom in terms of the practices judged from qualitative analysis to have been the least (top) to most (bottom) successful
implementers.
†Practice group in terms of when started the intervention (1= first group to start, 10= last group to start).
‡Mean practice rate of high-risk prescribing in the 2 years before starting the intervention.
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Table 3 Comparison of overall qualitative assessment of implementation and quantitative measures or reach, delivery, maintenance and effectiveness
Practice Overall qualitative assessment of implementation*
Reach % of eligible
patients† with a
review recorded at
any point during the
intervention period
Delivery to patients
% of eligible patients‡
with change in
prescribing recorded§
Maintenance
% of eligible patients‡
with a review recorded
in the final 24 weeks
of the intervention
Effectiveness
% reduction
in high-risk
prescribing¶
Orosay DQIP intervention was not adopted because there was a failure
to collectively legitimise the intervention. This was too much work
for one individual so no process for implementation was agreed
3 2 0.7 19
Boreray DQIP intervention was not adopted. Initially the GPs agreed to
share the work, but failed to implement any changes because of
understaffing and a prioritisation of clinical work
2 0 0 −24
Hellisay DQIP was adopted, initially delivered to patients but with low
maintenance. The GPs dealt with the initial bulk immediately but
staff changes meant they struggled to consistently maintain
reviewing
64 5 7 6
Mingulay DQIP was adopted with reasonable initial reach. One GP had
2 hours per month allocated to deliver review, but this was
inadequate to address the numbers identified with limited
communication with other GPs
62 29 48 28
Gighay DQIP was adopted with limited delivery to patients. They agreed
that one GP would review all patients and flag notes for when
next seen, so relied on patient consulting and other GPs acting
on the flag
83 14 43 56
Lingay DQIP intervention was not initially adopted. GPs initially agreed
to divide the work but problems with access to the informatics
tool led to lost motivation. DQIP was implemented fully by one
GP after a delay
78 32 44 53
Scalpay DQIP was fully implemented from the start. The practice did not
agree process at EOV but one GP reviewed all patients
95 19 50 67
Hirta DQIP was fully implemented from the start. The initial bulk of
work was divided among all GPs and then one GP maintained
reviewing
90 45 43 75
Monach DQIP was fully implemented from the start. The practice initially
agreed to divide the work but one GP actually did all the
reviewing
89 38 47 77
Taransay DQIP was fully implemented from the start. DQIP was delivered
by all GPs and co-ordinated by an administrative member of staff
92 33 68 59
*Ordered from top to bottom in terms of the practices judged from qualitative analysis to have been the least (top) to most (bottom) successful implementers.
†Eligible defined as patients with one or more high-risk prescriptions issued during the 48-week intervention period.
‡Eligible defined as patients with one or more high-risk prescriptions issued during the second half (24 weeks) of the intervention period.
§Patients without a review recorded were assumed not to have a change in prescribing.
¶Defined as the relative change in high-risk prescribing in each practice in the final 24 weeks of the intervention compared with the 48 weeks before the intervention started (negative numbers
indicate an increase in high-risk prescribing).
DQIP, Data-driven Quality Improvement in Primary Care.
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Failure to initially adopt the DQIP intervention. Three
practices failed to initially adopt the DQIP intervention,
although for different reasons and with different conse-
quences. In Orosay and Boreray, non-adoption was per-
sistent, whereas Lingay did adopt after a delay.
The GPs in Orosay never agreed how the work
required would be done, partly because of lack of agree-
ment that it was important to do. There was poor attend-
ance at the initial EOV and at a second visit requested
by the practice after ∼6 months. One GP in Orosay was
highly motivated and engaged, but one felt they had no
obligation to participate despite having received the
initial payment, and another did not believe the tar-
geted prescribing needed review.
How much risk is each individual patient at? What will
happen if we don’t do anything? This GP’s questioning
resulted in a long discussion with this GP arguing that he
had little experience of renal failure due to NSAIDs; he
said he is an old GP and his experience shapes his pre-
scribing. (Extract from ﬁeld notes 17.05.12)
During practice visits and during interviews in Orosay,
administrative staff indicated that working relationships
among GPs were frayed at times and there was a belief
that it was not appropriate for one GP to change
another’s prescribing. However, although patients were
not reviewed as intended, there was some evidence indi-
vidual GPs in Orosay did change their prescribing as a
result of the educational intervention.
Yeah it’s been because of DQIP really yes, aye. … It’s
merely made me sit up and pay a bit more attention…
It’s more now when I see them, and I didn’t even know if
their name’s on the tool. (Orosay, GP 1, interview 1)
In Boreray all GPs legitimised the work. The practice
did agree a process by which to do the work but they
never got started due to persistent clinical and adminis-
trative understafﬁng:
…we lost a partner… but the (other) doctors have cut
their hours, they havnae got time…so it’s kinda been a
wee bit o’ upheaval in the last few months. So I was
hoping they would take on a full-time Practice
Manager… but they’ve taken on a part-time one.
(Boreray, administrative interview)
As a result, the practice prioritised routine clinical
work, although at the ﬁnal interview, the GP said they
had not known that each reviewed patient earned a £15
payment, and that knowing this might have led to differ-
ent priorities.
Lingay experienced a ‘delayed implementation’.
When examining the practice data during the EOV, it
was obvious to the two GPs in the practice that many of
the patients identiﬁed usually consulted with one of
them. This GP was keen to review identiﬁed patients,
but this was delayed by informatics access problems and
little reviewing was initially done as motivation waned.
Subsequently, one of the GPs was temporarily unable to
do clinical work for health reasons which created time
for doing work like DQIP. Once started, the GPs became
highly motivated by seeing reductions in high-risk pre-
scribing, and this led them to change their appointment
system to protect speciﬁc time to do quality improve-
ment work.
…we are making changes as of this month, we are stag-
gering the times of surgeries so that there’s actually
going to be proper paperwork time. (Lingay, GP 1, inter-
view 2)
Failure to consistently reach patients targeted by the DQIP
intervention. In Mingulay, all professionals legitimised
DQIP, and agreed that one GP would do all the work in
2 hours dedicated administrative time per month.
However, this was not enough time for the GP to com-
plete the initial large volume of reviews, exacerbated by
the informatics tool initially running slowly (a problem
for some practices in the ﬁrst wave of implementation).
There was also poor communication with the other GPs
in the practice due to most being part-time with heavy
use of locums. The GPs doing the work, therefore, felt
that they never got on top of the reviewing, and per-
ceived that stopped prescribing was often restarted.
The ﬁrst few times we sort of went great guns and I got
right down to, I only had 5 to review and then of course
the next time I went on there was something like 19
‘cause obviously there had been a couple that had
re-triggered for whatever reason and then others that
had obviously come on in that time and it was very frus-
trating. (Mingulay, GP 1, interview 1)
Failure to deliver the DQIP intervention to patients. In
Gighay, one GP committed the practice to DQIP,
attended the EOV and carried out all the review work,
but made few changes, instead ﬂagging the patient’s
record for the attention of whichever GP next saw them.
As a result, GPs who had not received the educational
intervention (written educational materials were not
internally distributed) were responsible for delivering
the change in prescribing, and delivery was therefore
dependent on the patient attending for routine care and
on the GP seeing them responding to the ﬂag in the
record.
Failure to maintain delivery of the DQIP intervention to
patients. Hellisay was a two-GP practice where one GP
attended the EOV and rapidly started reviewing patients.
However, the other GP then left, and although a new
GP replaced them, the remaining original GP then went
off sick.
We blitzed the ﬁrst numbers that we had, we then drifted
along for a little bit doing some (reviews)… roundabout
Christmas we stopped doing DQIP ‘cause Christmas is, is
such a busy rush time, anyway DQIP dropped to the
bottom of the priority list. Pretty much after Christmas
Dr X went off sick. (Hellisay, GP 2, interview 1)
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Reviewing was therefore not maintained, although the
new partner said had they been aware of the ﬁnancial
incentive, it might have encouraged them to prioritise
DQIP over other work.
Case study practices which had large initial reductions in
high-risk prescribing
Four practices were sampled on the basis of having large
initial reductions in high-risk prescribing. In these prac-
tices, there was full attendance by virtually all prescribers
at the EOVs and there was strong and widespread legit-
imation and commitment to deliver. Two were small
practices which initially decided to share the review
work among all GPs, but within a couple of months of
starting, one more motivated and/or IT literate GP took
responsibility for the work because it was ‘not too
onerous for one GP’ (Scalpay, GP 1, interview 1). In the
two large practices, the initial review work and patient
communication was shared by all GPs. In Hirta, one GP
then took responsibility for subsequent review work and
consultations with patients, whereas in Taransay the
work continued to be shared across GPs and coordi-
nated by a member of administrative staff.
Maintenance
No practice felt DQIP put an unfeasible burden on prac-
tice resources although it clearly required time to review
records and communicate with patients, and two prac-
tices (Hellisay and Boreray) were unable to deliver the
intervention due to being understaffed and prioritising
competing demands. Most GPs delivered the required
work outside routine opening hours, although in three
practices, GPs used time already allocated for administra-
tive work. As a result, all practices primarily communi-
cated with patients by telephone. DQIP work was
therefore done as separate activity rather than fully inte-
grated with existing work, with only Lingay modifying
any broader processes or systems as a result of the DQIP
work.
Participants perceived that the review work inﬂuenced
their future prescribing, saying that the work was more
‘hands on’ than other prescribing interventions which
were pharmacist-led, and came with clear and concise
prescribing advice.
cause you’re thinking ‘oh …’, when you’re prescribing
anti-inﬂammatory, is there a reason I shouldn’t be or
should I prescribe a PPI as well, so I think it probably
does focus your mind. (Scalpay, GP 1, interview 1)
Since participants felt this applied less to GPs not
doing reviewing, they used a range of strategies to try to
prevent drugs being restarted without due consideration,
including informal discussion in the coffee room or in
practice meetings, and ﬂagging the notes with a
warning. GPs from the practices which successfully
reduced the targeted high risk prescribing continued to
check the tool to ensure no patients had been
incorrectly restarted on high-risk drugs and no new
patients had been prescribed the targeted medication,
and expressed concern that when the trial ended, they
would not be able to check this.
…the worry is of course when, when the project stops
whether things will drift back up again, I just wondered
if, if this software could be left running… … ‘cause I
think it’s very, very useful … I think, it’s like everything,
unless you’re constantly reminded of things it does, it
does, it does tend to slip a little bit. (Monach, GP 1, inter-
view 2)
Unintended consequences
Unintended consequences were explored in the inter-
views but none were identiﬁed.
Quantitative data in relation to qualitative assessment of
the extent of implementation
Table 2 summarises the qualitative assessment of the
extent of practice adoption and implementation made
before the trial results and quantitative process data
were known, and ordered from the least to most success-
ful adopters/implementers. It additionally shows quanti-
tative measures of reach, delivery to patients,
maintenance and effectiveness to contextualise the
qualitative judgement. The four practices sampled as
having rapid initial reductions in high-risk prescribing
(Scalpay, Hirta, Monach, Taransay) were all qualitatively
judged to have rapid and sustained adoption and imple-
mentation. These four practices also had the highest
quantitative measures of reach, and among the highest
measures of delivery and maintenance. They had among
the largest reductions in targeted high-risk prescribing
across all practices in the trial (ﬁgure 2).
The six practices sampled as having no initial reduction
in high-risk prescribing (assumed to be ‘initial
non-adopters’ during sampling) were more varied in
qualitative and quantitative assessment. Table 2 shows the
two practices qualitatively judged to have not adopted the
intervention at all (Orosay and Boreray) had very low
rates of reach, delivery and maintenance, all of which
were measured using data from the informatics tool.
Orosay did have a reduction in high-risk prescribing
consistent with qualitative data that there was change in
prescribing practice by at least some GPs even though
the informatics tool was never systematically used, but
high-risk prescribing increased in Boreray (table 2 and
ﬁgure 2). The other four practices sampled as having no
initial reduction in high-risk prescribing were qualita-
tively judged to have implemented with delay or in a way
which the practices themselves perceived as suboptimal.
They had generally intermediate levels of reach over the
whole intervention period (table 2). Consistent with the
qualitative data, Hellisay had limited delivery to patients
of changed prescribing or follow-up, and poor mainten-
ance with minimal change in the rate of high-risk pre-
scribing. The remaining three practices had somewhat
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lower but overlapping levels of delivery to patients com-
pared with the successful implementers, with similar rates
of maintenance, and somewhat lower rates of effective-
ness, consistent with the qualitative interpretation that
these practices had delayed but ultimately successful
implementation (table 2 and ﬁgure 2).
DISCUSSION
This study examined implementation of the DQIP inter-
vention in 10 practices (30% of trial practices) purpos-
ively selected for variation in initial reduction in
targeted high-risk prescribing, which we assumed was a
proxy for initial adoption and implementation. For the
four practices selected on the basis of early reductions
in high-risk prescribing, qualitative and quantitative data
showed evidence of rapid and sustained adoption and
implementation, and they were among the most effect-
ive in terms of practice-level change in high-risk pre-
scribing. Our sample included all the six practices which
had no initial reduction in high-risk prescribing and
these were all judged qualitatively to either have not
adopted at all because of disagreement about the value
of the work, or to have experienced delay in implemen-
tation related to their organisational context, and the
quantitative measures were largely consistent with the
qualitative interpretation.
The way that practices did the work of implementation
did therefore appear to be associated with effectiveness.
An attractive theoretical lens to examine this work is
NPT.20 The NPT construct coherence refers to participants’
understanding of the intervention. Interviewed profes-
sionals in all practices clearly perceived the intervention
and the associated review work as different from existing
quality improvement work because of its focus on safety
rather than cost. Cognitive participation relates to the
enrolment and engagement of practices and clinicians
to the DQIP work. In all practices, there was at least one
engaged GP, but collective engagement varied across
other GPs. Most or all GPs in nine of the case study prac-
tices highly legitimised the DQIP intervention, perceiv-
ing this as an innovative way to address an important
safety problem. However, in the one practice where
there was openly stated disagreement about value, imple-
mentation of the intervention failed from the outset
(although there was evidence of change in prescribing
Figure 2 All trial practices
ranked in order of intervention
effectiveness, with case study
practices identified. Practices
marked in green were sampled
because they were judged to
have initially rapidly reduced the
targeted prescribing; practices
marked in red were sampled
because they were judged to
have not initially reduced the
targeted prescribing.
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practice by GPs who did legitimise the work and of
reduction in high-risk prescribing, contrary to our belief
that use of the informatics tool would be required for
effectiveness).
Collective action focuses on how practices organised the
work required for DQIP, which was usually as a separate
activity rather than fully integrated with existing work or
practice routines. In the smaller practices, which success-
fully implemented the intervention immediately or with
delay, one GP did all the reviewing partly because the
numbers made this feasible (contrary to our prior belief
that intervention effectiveness would require sharing of
the work). In the larger practices, the initial bulk of
work was shared between GPs which required coordin-
ation by an administrator, but continued reviewing was
shared or taken on by the most engaged GP.
Reﬂexive monitoring is about how participants assessed
their progress in delivering the intervention, and
responded to problems. Many GPs in practices which
successfully implemented the intervention said that they
regularly checked the tool to monitor progress.
Interviewed GPs perceived that reviewing altered their
future prescribing but were concerned that this did not
apply to their colleagues. They described using a
number of strategies to try to inﬂuence colleague’s pre-
scribing to try to ensure sustainability but were uncertain
whether this was effective (although the main trial ana-
lysis found signiﬁcant reductions in new high-risk pre-
scribing, and that reductions in total high-risk
prescribing were sustained in the 48 weeks after ﬁnancial
incentives ceased).12
Overall, coherence appeared uniformly high across case
study practices (perhaps unsurprising in practices volun-
teering to participate in a trial), and so did not appear
to inﬂuence implementation. However, varied percep-
tions of the legitimacy of the work and low engagement
(cognitive participation) signiﬁcantly contributed to poor
adoption in two practices. More successful practices
delivered the intervention in a variety of ways which did
not always match the research teams’ prior beliefs about
how best to deliver the intended care, highlighting that
allowing practices ﬂexibility to implement in ways that
worked for them was important (collective action).
Successful implementers also regularly reviewed their
progress, and used a range of strategies to change their
colleagues’ practice to address their own concerns about
sustainability (reﬂexive monitoring).
Our other qualitative process evaluation paper reports
that practice participants perceived all primary compo-
nents of the intervention delivered to them by the
research team to be active (ﬁnancial incentives, educa-
tion, informatics).19 This paper complements and
extends those ﬁndings by examining how practices actu-
ally responded to the intervention delivered to them by
adopting and implementing the work of delivering
changed care to patients. They are also consistent with
the quantitative examination of variation in effectiveness
(Dreischulte et al 2016, Submitted). Six of the 10 case
study practices were sampled because they did not ini-
tially reduce high-risk prescribing (assumed to be initial
implementation failures), but most had delayed imple-
mentation and did achieve reductions in targeted pre-
scribing. The practice where qualitative and quantitative
data were most incongruent was Orosay, which was quali-
tatively judged to be an implementation failure (true in
the sense that it made no use of the informatics tool
and claimed no payments for reviewing), but which had
a 19% reduction in targeted high-risk prescribing, con-
sistent with the educational intervention altering clinical
practice. This supports the idea that multicomponent
interventions to change professional practice may be
somewhat more effective than single-component inter-
ventions, since professionals or the organisations they
work in may vary in how they respond (or not) to differ-
ent elements.
In the wider literature, the intervention evaluated in
the pharmacist-led information technology intervention
for medication errors (PINCER) trial is the closest to
DQIP in design and focus.23 Signiﬁcant differences were
that PINCER was pharmacist-led and delivered over
12 weeks, and that PINCER had a more standardised
intervention in terms of how the pharmacists completed
reviews. The PINCER process evaluation found that
some of the pharmacists doing reviews did not feel well
integrated into the practice team, found the work repeti-
tive and would have preferred some ﬂexibility to tailor
the intervention to different practice contexts.24 Both
interventions showed large reductions in targeted pre-
scribing, but the DQIP intervention had sustained effects
48 weeks after the intervention ceased whereas the
PINCER effect at 12 months was somewhat smaller than
at 6 months.23 The DQIP ﬁndings suggest that GP-led
reviewing may lead to more sustainable change by
having greater inﬂuence on less involved GPs, and by
changing future initiation of high-risk prescribing.
However, since both studies were carried out in volunteer
practices, it is likely that non-volunteer practices will
require greater effort to engage and greater support to
deliver similar outcomes which has implications for
implementation across entire healthcare systems. From
this perspective, pharmacist-led interventions have the
potential advantage that it may be easier to deliver at
least some change in practices which are less engaged or
which are resource constrained.24
These ﬁndings are likely to be generalisable beyond
this immediate study and context. For example,
Kennedy et al found that the Whole System Informing
Self-management Engagement (WISE) intervention was
not routinely adopted by practices because it was not
perceived as relevant or legitimate activity or a priority
for general practice, and it did not ﬁt within existing
work. These ﬁndings align with the ﬁndings of this study
that lack of coherence and cognitive participation were
important barriers to implementation, and therefore
may be important targets for intervention.25 Likewise,
Berendsen et al26 found the BeweegKuur (combined
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lifestyle intervention) was not implemented according to
protocol and had poor sustainability because patient’s
expectations of the intervention were not met and tailor-
ing to general practice and patient contexts was
required. Moore et al27 have also shown how implemen-
tation of an exercise intervention varied by patient
characteristics and context. Like this study, the process
evaluation of the implementation of the telephone
triage for management of same-day consultation
requests in general practice (ESTEEM) trial comparing
GP versus nurse telephone triage of same-day appoint-
ment requests highlighted the importance of context on
intervention implementation, and suggested that allow-
ing autonomy to deliver the intervention to suit practice
and patient contexts was likely important for effective
implementation.28
Our published paper examining professional percep-
tions of the key components of the intervention deliv-
ered to practices (education, ﬁnancial incentives and
the informatics tool) found that all components were
‘active’ although at different stages of recruitment and
adoption.19 This paper adds to that, within a clear deﬁn-
ition of the work practices were expected to do with
patients, allowing them the freedom to tailor implemen-
tation and develop their own processes to suit their
context was important for effective implementation. The
paper also shows that characteristics associated with
implementation varied with context. Having a single
motivated individual GP in small practices appeared to
be sufﬁcient for effective implementation, but shared
vision and joint working additionally appeared import-
ant in larger practices.
STRENGTHS AND LIMITATIONS
A strength of the study overall is that we were sufﬁciently
resourced to develop and published a preplanned and
prespeciﬁed study18 and carry out a well-resourced and
rigorous process evaluation of a third of all practices
included in the trial (Dreischulte et al 2016,
Submitted).19 A strength of this analysis is the attention
to context, illustrating its inﬂuence on intervention
implementation including that context is not ﬁxed, for
example, in relation to variable stafﬁng over time. The
sampling method we chose has advantages and disad-
vantages. Using run charts showing change in the tar-
geted high-risk prescribing, we chose to sample six
practices which did not appear to have implemented the
intervention, and four practices which had. We felt that
purposive sampling for heterogeneity in this way would
help us more clearly understand the barriers and facili-
tators to trial delivery and intervention implementation.
We recognise that sampling from the two ends of the dis-
tribution of initial response may limit generalisability to
a wider population, but this is mitigated by the fact that
we included one third of practices participating in the
trial in the process evaluation. In principle, it also risks
regression to the mean where outliers from both ends of
the distribution would be expected to become more
similar to each other because being an outlier at one
time point may be due to chance variation. We do not
believe this was the case here, because the four initial
responders remained among the most effective at trial
end, and the two initial non-responders which delivered
the largest reductions in high-risk prescribing by trial
end were both judged qualitatively (blind to ﬁnal trial
results) to have signiﬁcantly implemented after a delay.
CONCLUSIONS
The DQIP intervention successfully reduced targeted
high-risk prescribing12 and reductions were sustained in
the 48 weeks after the intervention ceased. Overall, the
four case study practices which immediately implemen-
ted the DQIP intervention had full or nearly full GP
attendance at the EOV consistent with collective engage-
ment, rapidly identiﬁed and implemented a process for
delivering the required work, and had at least one
engaged and motivated GP who used a range of strat-
egies to try to inﬂuence their colleagues’ prescribing. In
contrast, the six practices in which implementation was
problematic were more variable, with initial implementa-
tion failure occurring at different stages of adoption and
often being linked to wider practice context or
resources. Context and resources were however not
ﬁxed, with most of the initial implementation ‘failures’
delivering some or all elements of the intervention,
leading to successful reductions in targeted high-risk
prescribing. In wider implementation, commissioners
should pay careful attention to deploying educational
and persuasive strategies to ensure practices legitimise
the work, should allow practices freedom to tailor how
they implement the work of review, and should seek to
offer additional support and facilitation to practices
struggling with short-term resource constraint or other
contextual barriers early in implementation.
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